Study S002036

Efficacy and Tolerance of Liraglutide for Weight Loss in Obese Type 2 Diabetic Hemodialysis Patients

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT04529278
Acronym: LIRADIAL
Study type: INTERVENTIONAL
Phase: PHASE2
Masking: NONE
Status: UNKNOWN
Enrollment: 18
Start: 2021-01-18
Primary completion: 2023-01-17
Lead sponsor: Fondation Hôpital Saint-Joseph
Conditions: Diabetes Mellitus, Type 2; Hemodialysis; Obese
Interventions: DRUG:Liraglutide
Results posted: FALSE

Registered primary outcomes

Weight Loss at Week 26 [Week 26]

Linked records (7)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0018235	Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. O'Neil PM, Lancet (London, England)	2018	Randomized trial	PMID 30122305 DOI	registry reference RESULT:30122305
R0025215	Clinical effectiveness of liraglutide vs basal insulin in a real-world setting: Evidence of improved glycaemic and weight control in obese people with type 2 diabetes. Overbeek JA, Diabetes, obesity & metabolism	2018	Nonrandomized study	PMID 29726082 DOI	registry reference RESULT:29726082
R0021512	Liraglutide and Renal Outcomes in Type 2 Diabetes. Mann JFE, The New England journal of medicine	2017	Randomized trial	PMID 28854085 DOI	registry reference RESULT:28854085
R0026106	Safety and Efficacy of Liraglutide in Patients With Type 2 Diabetes and End-Stage Renal Disease: An Investigator-Initiated, Placebo-Controlled, Double-Blind, Parallel-Group, Randomized Trial. Idorn T, Diabetes care	2016	Randomized trial	PMID 26283739 DOI	registry reference RESULT:26283739
R0026109	Effect of hemodialysis on plasma glucose profile and plasma level of liraglutide in patients with type 2 diabetes mellitus and end-stage renal disease: a pilot study. Osonoi T, PloS one	2014	Nonrandomized study	PMID 25526642 DOI	registry reference RESULT:25526642
R0019848	Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study. Nauck M, Diabetes care	2009	Randomized trial	PMID 18931095 DOI	registry reference RESULT:18931095
R0027293	Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Astrup A, Lancet (London, England)	2009	Randomized trial	PMID 19853906 DOI	registry reference RESULT:19853906